CM
Chad Messer Lake Street Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Immunome
IMNM
$916M
| $10.52 | $23 |
119%
upside
| Buy | 5 months ago |
|
2
Esperion Therapeutics
ESPR
$540M
| $2.68 | $114 |
4,154%
upside
| Strong Buy | 4 years ago |
|
3
Celcuity
CELC
$2.36B
| $55.69 | $50 |
10%
downside
| Buy | 4 years ago |
|
4
Cytokinetics
CYTK
$6.34B
| $53.01 | $48 |
9%
downside
| Buy | 4 years ago |
|
5
Exelixis
EXEL
$10.2B
| $37.88 | $30 |
21%
downside
| Buy | 4 years ago |
|
6
Avidity Biosciences
RNA
$6.48B
| $50.36 | $50 |
1%
downside
| Buy | 4 years ago |
|
7
CorMedix
CRMD
$926M
| $12.40 | $29 |
134%
upside
| Buy | 4 years ago |
|
|
MREO
8
Mereo BioPharma
MREO
$282M
| $1.77 | $10 |
465%
upside
| Buy | 4 years ago |
|
9
Ionis Pharmaceuticals
IONS
$9.76B
| $61.23 | $86 |
40%
upside
| Buy | 4 years ago |
|
|
IMAB
10
I-MAB
IMAB
$358M
| $4.38 | $75 |
1,612%
upside
| Buy | 4 years ago |
|
11
Nurix Therapeutics
NRIX
$758M
| $9.91 | $44 |
344%
upside
| Buy | 4 years ago |
|
12
Sarepta Therapeutics
SRPT
$1.96B
| $18.71 | $166 |
787%
upside
| Buy | 4 years ago |
|
13
Akebia Therapeutics
AKBA
$785M
| $2.96 | $18 |
508%
upside
| Buy | 5 years ago |
|